The contemporary metabolic health and weight management landscape across the United States, the United Kingdom, Germany, Japan, China, Canada, France, the Netherlands, Switzerland, Australia, Dubai, Finland, and Austria is experiencing a transformative paradigm shift. As clinical researchers, endocrinologists, and public health authorities evaluate advanced pharmacological solutions for chronic metabolic conditions, incretin-based therapies have emerged as […]